Stocks and Investing
Stocks and Investing
Tue, January 25, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 24, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (ABBV) at Buy with Increased Target to $142 on, Jan 24th, 2022
Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $124 to $142 on, Jan 24th, 2022.
Matthew has made no other calls on ABBV in the last 4 months.
There are 13 other peers that have a rating on ABBV. Out of the 13 peers that are also analyzing ABBV, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $133 on, Thursday, January 20th, 2022
- Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $113 on, Friday, December 17th, 2021
- Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
These are the ratings of the 10 analyists that currently disagree with Matthew
- Christopher Raymond of "Piper Sandler" Reiterated at Buy and Held Target at $160 on, Tuesday, January 18th, 2022
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $150 on, Tuesday, January 18th, 2022
- Charles Pitman of "Redburn Partners" Initiated at Strong Buy on, Thursday, January 13th, 2022
- Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $153 on, Wednesday, January 12th, 2022
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, January 5th, 2022
- Aaron Gal of "Bernstein" Maintained at Buy with Increased Target to $155 on, Monday, January 3rd, 2022
- Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
- Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
Contributing Sources